When to opt for preemptive anticoagulation with SARS-CoV-2 infection in the long-term care facilities

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Aging clinical and experimental research 2022-12, Vol.34 (12), p.3171-3177
Hauptverfasser:	Mujahid, Nadia, Rajan, Ashna, Abul, Yasin, Vura, Naga Venkata Rama Krishna, Neupane, Iva, LaPlante, Kerry, Gravenstein, Stefan
Format:	Artikel
Sprache:	eng
Schlagworte:	Anticoagulants Anticoagulants - therapeutic use Blood Coagulation Cardiovascular disease Coronaviruses COVID-19 Disease prevention Drug dosages Embolisms Geriatrics Geriatrics/Gerontology Hospitalization Hospitals Humans Infections Long term health care Long-Term Care Medicine Medicine & Public Health Monoclonal antibodies Mortality Nursing homes Older people Palliative care Pandemics Point of View SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Thromboembolism Thrombosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!